Investor:
Lior Handelsman
Leadership team:
Eran Seger, Kirill Pevzner
Website:
www.protai.bio

Protai is an AI-powered drug discovery startup that combines deep proteomics research with machine learning to better combat complex diseases and create a healthier world.

  • SDG: 3 – Good health and wellbeing
  • Protenomics
  • Drug Discovery
  • AI
  • Computational Biology
  • BioMed

We know we can rely on Grove Ventures for any type of support for our business. Their entire team is great and responsive, and they work as fast as we do.

Eran Seger, CEO and Co-Founder, Protai

Top news

Israeli AI drug discovery co Protai raises $8m

How Protai’s AI-powered platform is improving drug discovery

Protai Adds $12 Million to Seed Round

3 Grove Ventures Portcos – NoTraffic, Protati, OneLayer – at Calcalist’s Top 50 Most Promising Startups